Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension

被引：2
|
作者：
Miura, Yohei [1 ]
Kataoka, Masaharu [3 ]
Chiba, Tomohiro [2 ]
Inami, Takumi [1 ]
Yoshino, Hideaki [1 ]
Satoh, Toru [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan
来源：
CIRCULATION JOURNAL | 2018年 / 82卷 / 10期
关键词：
Epoprostenol; Giant fold gastritis; Pulmonary arterial hypertension; Stomach barium examination; THERAPY;
D O I：
10.1253/circj.CJ-18-0349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Epoprostenol infusion is the strongest and most convincing therapeutic strategy for severe pulmonary arterial hypertension (PAH). This study investigated the gastrointestinal side effects of epoprostenol. Methods and Results: The study group of 12 patients treated with epoprostenol (epoprostenol group) and 4 patients without epoprostenol (control group) underwent stomach barium examination, which revealed that the prevalence of giant fold gastritis was significantly higher in the patients treated with epoprostenol (75% in epoprostenol group vs. 0% in control group; P=0.019). Conclusions: Giant fold gastritis may be an important side effect of epoprostenol infusion.
引用
收藏
页码：2676 / 2677
页数：2
相关论文
共 50 条
  • [11] Epoprostenol sodium for treatment of pulmonary arterial hypertension
    Saito, Yukihiro
    Nakamura, Kazufumi
    Akagi, Satoshi
    Sarashina, Toshihiro
    Ejiri, Kentaro
    Miura, Aya
    Ogawa, Aiko
    Matsubara, Hiromi
    Ito, Hiroshi
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 265 - 270
  • [12] Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
    Mohammadi, Asma
    Matos, Wanessa F.
    Intriago, Cesar
    Thakkar, Keval
    Jahan, Nasrin
    Shah, Heeya
    Nishu, Rifath I.
    Marzban, Sima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [13] The experiences of patients with Pulmonary Arterial Hypertension (PAH) receiving continuous intravenous infusion of epoprostenol (Flolan™), and their support persons
    Hall, Heather
    Cote, Joanne
    McBean, Althea
    CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 323C - 323C
  • [14] Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol
    Kuhn, KP
    Byrne, DW
    Arbogast, PG
    Doyle, TP
    Loyd, JE
    Robbins, IM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (04) : 580 - 586
  • [15] How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst, R.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 23 - 32
  • [16] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Demerouti, Eftychia
    Karyofyllis, Panagiotis
    Manginas, Athanassios
    Anthi, Anastasia
    Karatasakis, George
    Athanassopoulos, George
    Voudris, Vassilios
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2019, 19 (02) : 99 - 105
  • [17] Improving Survival in Patients with Pulmonary Arterial Hypertension: Focus on Intravenous Epoprostenol
    Eftychia Demerouti
    Panagiotis Karyofyllis
    Athanassios Manginas
    Anastasia Anthi
    George Karatasakis
    George Athanassopoulos
    Vassilios Voudris
    American Journal of Cardiovascular Drugs, 2019, 19 : 99 - 105
  • [18] Experience of Epoprostenol Infusion in Patients With Right Heart Failure Secondary to Pulmonary Hypertension
    Fernandez, Liliana
    Gomez, Juan
    Arango, Natalia
    Cantillo, Santiago
    Martinez, William
    Sanabria, Fernando
    Carrillo, Diana
    Rincon, Erika
    CHEST, 2016, 150 (04) : 1165A - 1165A
  • [19] Urticaria induced by continuous intravenous epoprostenol treatment in a patient with pulmonary arterial hypertension
    Sawada, Tomoya
    Kuwai, Takumi
    Nakajima, Saeko
    Chen-Yoshikawa, Toyofumi Fengshi
    Nomura, Takashi
    Date, Hiroshi
    Kabashima, Kenji
    JOURNAL OF DERMATOLOGY, 2024,
  • [20] Effect of epoprostenol-induced thrombocytopaenia on lung transplantation for pulmonary arterial hypertension
    Date, Naoki
    Nakajima, Daisuke
    Ikeda, Masaki
    Nishikawa, Shigeto
    Tanaka, Satona
    Yamada, Yoshito
    Yutaka, Yojiro
    Hamaji, Masatsugu
    Menju, Toshi
    Ohsumi, Akihiro
    Date, Hiroshi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 65 (04)
12345